Home › Trial NCT03859128
Toripalimab or Placebo as Adjuvant Therapy in Hepatocellular Carcinoma After Radical Resection
- Trial IDNCT03859128
- StatusActive Not Recruiting
- PhasePhase 2/3
- Study typeInterventional
- SponsorShanghai Junshi Bioscience Co., Ltd.
- Enrollment427
- Start date2019-03-05
- ConditionsHepatocellular Carcinoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.